MyFinsight
Home
About
Contact
imcr: the income statement
Download
Download image
International
$2,867K
Europe
$33,526K
US
$67,300K
Total comprehensive
(loss) income
-$3,569K
(-129.78%↓ Y/Y)
Other income, net
$5,062K
(-43.52%↓ Y/Y)
Foreign currency gain
$1,333K
(-66.36%↓ Y/Y)
Interest income
$4,123K
(-30.82%↓ Y/Y)
Sale Of Therapies
$103,693K
Exchange differences on
translation of foreign...
-$3,392K
(-204.47%↓ Y/Y)
Net (loss) income
-$177K
(-102.03%↓ Y/Y)
Net income (loss)
before income taxes
$304K
(-95.01%↓ Y/Y)
Interest expense
$3,043K
(-29.07%↓ Y/Y)
Loss from operations
-$7,171K
(15.66%↑ Y/Y)
Total revenue
$103,693K
(29.22%↑ Y/Y)
Income tax (expense)
benefit
$481K
(118.20%↑ Y/Y)
Selling, general and
administrative expense
$39,779K
(11.95%↑ Y/Y)
Research and development
expense
$70,572K
(33.74%↑ Y/Y)
Cost of revenue from
sale of therapies
$513K
(14.51%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR)